[HTML][HTML] A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled …
…, K Jiang, C Mariottini, M McMahon, M McNeal… - Nature medicine, 2021 - nature.com
Seasonal influenza viruses constantly change through antigenic drift and the emergence of
pandemic influenza viruses through antigenic shift is unpredictable. Conventional influenza …
pandemic influenza viruses through antigenic shift is unpredictable. Conventional influenza …
Respiratory syncytial virus–associated hospitalizations among young children: 2015–2016
…, R Selvarangan, NB Halasa, MM McNeal… - …, 2020 - publications.aap.org
BACKGROUND: Respiratory syncytial virus (RSV) is a major cause of hospitalized acute
respiratory illness (ARI) among young children. With RSV vaccines and immunoprophylaxis …
respiratory illness (ARI) among young children. With RSV vaccines and immunoprophylaxis …
[HTML][HTML] Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-γ in experimental biliary atresia
…, A Miethke, G Tiao, MM McNeal… - The Journal of …, 2004 - Am Soc Clin Investig
The etiology and pathogenesis of bile duct obstruction in children with biliary atresia are largely
unknown. We have previously reported that, despite phenotypic heterogeneity, genomic …
unknown. We have previously reported that, despite phenotypic heterogeneity, genomic …
Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial
…, CB Turley, LR Stanberry, SM Patel, MM Mcneal… - Vaccine, 2016 - Elsevier
Background Cytomegalovirus (CMV) is a leading cause of congenital infection and an
important target for vaccine development. Methods CMV seronegative girls between 12 and 17 …
important target for vaccine development. Methods CMV seronegative girls between 12 and 17 …
[HTML][HTML] IgA and neutralizing antibodies to influenza a virus in human milk: a randomized trial of antenatal influenza immunization
Background Antenatal immunization of mothers with influenza vaccine increases serum
antibodies and reduces the rates of influenza illness in mothers and their infants. We report the …
antibodies and reduces the rates of influenza illness in mothers and their infants. We report the …
[HTML][HTML] Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial
Background Influenza immunisation during pregnancy is recommended but not widely
implemented in some low-income regions. We assessed the safety and efficacy in mothers and …
implemented in some low-income regions. We assessed the safety and efficacy in mothers and …
The burden of influenza in young children, 2004–2009
…, GA Weinberg, SS Chaves, Y Zhu, MM McNeal… - …, 2013 - publications.aap.org
OBJECTIVE: To characterize the health care burden of influenza from 2004 through 2009,
years when influenza vaccine recommendations were expanded to all children aged ≥6 …
years when influenza vaccine recommendations were expanded to all children aged ≥6 …
[HTML][HTML] Efficacy of a low-cost, heat-stable oral rotavirus vaccine in Niger
…, N Sayinzoga-Makombe, MM McNeal… - … England Journal of …, 2017 - Mass Medical Soc
Background Each year, rotavirus gastroenteritis is responsible for about 37% of deaths from
diarrhea among children younger than 5 years of age worldwide, with a disproportionate …
diarrhea among children younger than 5 years of age worldwide, with a disproportionate …
Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children< 5 years of age, 2009–2011
…, MA Rench, S Donauer, M McNeal… - Clinical infectious …, 2013 - academic.oup.com
Background We assessed vaccine effectiveness (VE) for RotaTeq (RV5; 3 doses) and Rotarix
(RV1; 2 doses) at reducing rotavirus acute gastroenteritis (AGE) inpatient and emergency …
(RV1; 2 doses) at reducing rotavirus acute gastroenteritis (AGE) inpatient and emergency …
Predicting susceptibility to norovirus GII. 4 by use of a challenge model involving humans
…, S Parker, M Dickey, M McNeal… - The Journal of …, 2012 - academic.oup.com
Background. GII.4 is the predominant norovirus genotype worldwide. Challenge models
involving humans have shown the association of human histo-blood group antigens (HBGAs) …
involving humans have shown the association of human histo-blood group antigens (HBGAs) …